Context Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Deep Track Capital, LP(9.89%),Deep Track Biotechnology Master Fund, Ltd.(9.89%), etc.
Context Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Deep Track Capital, LP(9.89%),Deep Track Biotechnology Master Fund, Ltd.(9.89%), etc.
Context Therapeutics | SC 13G：超过5%持股股东披露文件-Deep Track Capital, LP(9.89%),Deep Track Biotechnology Master Fund, Ltd.(9.89%)等
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。